medica glp-1 coverage Medicaid of and Spending on GLP-1s Have you heard? There's a

Through Week 54, the overall incidence of hypoglycemia was 3.9% in patients given add-on sitagliptin and 1% in patients given add-on placebo

Unexpectedly, patients often report distinct subjective experiences of hunger and satiety on forums devoted to GLP-1 agonist non-responders, yet objective measures reveal minimal variation between response groups

What should patients, physicians, insurers, policy makers, and researchers know about GLP-1 cost, access, and safety

From the surge in demand leading to shortages for diabetic patients to the ethical debates surrounding accessibility and societal beauty standards, Ozempic is more than just a weight loss drug

Furthermore, GLP-1s interact with the central nervous systemspecifically targeting the hypothalamus, the brain region that controls appetite

Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance, convened leading rheumatologists and people living with lupus for the first in our webinar series, Lupus & Life: Science, Support, and Self-Care, to take a closer look at lupus and heart health